Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3625-3632

  Whalen, Janey D ^a   Lechman, Eric L ^b   Carlos, Casey A ^a   Weiss, Kurt ^a   Kovesdi, Imre' ^c   Glorioso, Joseph C ^b   Robbins, Paul D ^b   Evans, Christopher H ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c GENVEC INC   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN TYPE 2; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; GENE THERAPY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS GENE;

EID: 0033559906     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.162.6.3625     Document Type: Article

References (63)

1. Paulus, H. E. 1990. Antirheumatic drugs. In Internal Medicine, 3rd Ed. J. H. Stein, ed. Little Brown, Boston, pp. 1789-1795.
2. Schlegel, S. I., and H. E. Paulus. 1986. Nonsteroidal antiinflammatory drugs: use in rheumatic disease, side effects and interactions. Bull. Rheum. Dis. 36:1.
3. Weiss, M. M. 1989. Corticosteroids in rheumatoid arthritis. Semin. Arthritis Rheum. 19:9.
4. Furst, D. E. 1990. Rational use of disease modifying anti-rheumatic drugs. Drugs 39:19.
5. Brooks, P. 1993. Slow-acting antirheumatic drugs and cytotoxic agents. In Primer on the Rheumatic Diseases, 10th Ed. H. R. Schumacher, ed. Arthritis Foundation, Atlanta, pp. 303-306.
6. Arend, W. P., and J. M. Dayer. 1995. Inhihition of the production and effects of interleukin-1 and minor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38:151.
7. Brennan, F. M., D. Chantry, A. Jackson, R. N. Maini, and M. Feldmann. 1989. Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:224.
8. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Katsikis, F. M. Brennan, J. Walder, H. Bijl, J. Ghrayeb, and J. N. Woody. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum. 36:1681.
9. Dayer, J. M., and H. Fenner. 1992. The role of cytokines and their inhibitors in arthritis. Baillieres Clin. Rheumatol. 6:485.
10. Wooley, P. H., J. D. Whalen, D. L. Chapman, A. E. Berger, K. A. Richard, D. G. Aspar, and N. D. Staite. 1993. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum. 36:1305.
11. Lewthwaite, J., S. M. Blake, T. M. Hardingham, P. J. Warden, and B. Henderson. 1994. The effect of recombinant human IL-1 receptor antagonist on the induction of antigen-induced arthritis in the rabbit. J. Rheumatol. 21:467.
12. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of interleukin-1 activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated-acute phase response. Clin. Exp. Rheumatol. 11:515.
13. Van den Berg, W. B., L. A. Joosten, M. Helsen, and F. A. J. Van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.
14. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor α ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
15. Piguet, P. F., G. E. Grau, C. Vesin, H. Loetscher, R. Gentz, and W. Lesslauer. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumor necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510.
16. Wooley, P. H., J. Dutcher, M. B. Widmer, and S. Gillis. 1993. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J. Immunol. 151:6602.
17. Elliot, M. J., R. N. Maini, M. Feldmann, A Long-Fox, P. Charles, H. Bijl, and J. N. Woody. 1994. Repeated therapy with monoclonal antibody to tumor necrosis factor (cA2) in patients with rheumatoid arthritis. Lancet 344:1125.
18. + T cell counts. Arthritis Rheum. 37:834.
19. Kavanaugh, A. F., L. S. Davis, L. A. Nichols, S. H. Norris, R. Roghlein, L. A. Scharschmidt, and P. E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule I. Arthritis Rheum. 37:992.
20. Evans, C. H., and P. D. Robbins. 1994. Prospects for treating arthritis by gene therapy. J. Rheumatol. 21:779.
21. Nita, I., S. C. Ghivizzani, J. Galea-Lauri, G. Bandara, H. I. Georgescu, P. D. Robbins, and C. H. Evans. 1996. Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. 39:820.
22. Bandara, G., G. M. Mueller, J. Galea-Lauri, M. H. Tindal, H. I. Georgescu, M. K. Suchanek, G. L. Hung, J. C. Glorioso, P. D. Robbins, and C. H. Evans. 1993. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 90: 10764.
23. Otani, K., I. Nita, W. Macaulay, H. I. Georgescu, P. D. Robbins, and C. H. Evans. 1996. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J. Immunol. 156:3558.
24. Le, C. H. G. Nicolson, A. Morales, and D. L. Sewell. 1997. Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor receptor gene. Arthritis Rheum. 40:1662.
25. Bessis, N., G. Chiocchia, G. Kollias, A. Minty, C. Fournier, D. Fradelizi, and M. C. Boissier. 1998. Modulation of proinflammatory cytokine production in tumor necrosis factor-α (TNF-α)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin. Exp. Immunol. 111:391.
26. Chernajovsky, Y., G. Adams, O. L. Podhajcer, G. M. Mueller, P. D. Robbins, and M. Feldmann. 1995. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor α receptor. Gene Ther. 2:731.
27. Bessis, N., M. C. Boissier, P. Ferrara, T. Blankenstein, D. Fradelizi, and C. Fournier. 1996. Attenuation of murine collagen-induced arthritis by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26:2399.
28. Bakker, A. C., L. A. Joosten, O. J. Arntz, M. M. Helsen, A. M. Bendele, F. A. van de Loo, and W. B. van den Berg. 1997. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interlelikin-1 receptor antagonist protein in the knee. Arthritis Rheum. 40:893.
29. Makarov, S. S., J. C. Olsen, W. N. Johnston, S. K. Anderle, R. R. Brown, A. S. Baldwin Jr., J. S. Haskill, and J. H. Schwab. 1996. Suppression of experimental arthritis by gene transfer of interleukin-1 receptor cDNA. Proc. Natl. Acad. Sci. USA 93:402.
30. Zhang, H., Y. Yang, J. L. Horton, E. B. Samoilova, T. A. Judge, L. A. Turka, J. M. Wilson, and Y. Chen. 1997. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1951.
31. Apparailly, F., C. Verwaerde, C. Jacquet, C. Auriault, J. Sany, and C. Jorgensen. 1998. Aderovirus mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160:5213.
32. Kozarsky, K. F., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499.
33. Gunzburg, W. H., and B. Salmons. 1995. Virus vector design in gene therapy. Mol. Med. Today 1:410.
34. Treco, D. A., and R. F. Selden. 1995. Non-viral gene therapy. Mol. Med. Today 1:314.
35. Gorecki, D. C., and K. D. MacDermot. 1997. Gene therapy: panacea or placebo? I. Strategies and limitations of gene therapy. Arch. Immunol. Ther. Exp. (Warsz) 45:367.
36. Trentham, D. E., A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 46:857.
37. Courtenay, J. S., M. J. Dallman, A. B. Dayan, A. Martin, and B. Mosedale. 1980. Immunization against heterologous type II collagen induces arthritis in mice. J. Clin. Invest. 69:673.
38. Wooley, P. H., H. S. Luthra, J. M. Sturart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. 1. Major histocompalibility complex (1-region) linkage and antibody correlates. J. Exp. Med. 154:688.
39. Holmdahl, R., M. Andersson, T. J. Goldschmidt, K. Gustafsson, L. Jansson, and J. A. Mo. 1990. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunity. Rev. 118:193.
40. De Waal-Malefyt, R., H. Yssel, M. G. Roncaroio, H. Spits, and J. E. De Vries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314.
41. Fiorentino, D. F., A. Zlotnik, T. R. Mossmann, M. Howard, and A. O'Garra. 1991. II.-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
42. De Waal-Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. De Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
43. Kasama, T., R. M. Strieter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel. 1994. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152:3559.
44. Wang, P., P. Wu, J. C. Anthes, M. I. Siegel, R. W. Egan, and M. M. Billah. 1994. Interleukin-10 inhibits interleukin 8 production in human neutrophils. Blood 83: 2678.
45. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
46. Dickensheets, H. L., S. L. Freeman, M. F. Smith, and R. P. Donnelly. 1997. Interleukin-10 up-regulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulaled human monocytes. Blood 90:4162.
47. Joosten, L. A., F. Lubberts, P. Durez, M. M. Helsen, M. J. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
48. Walmsley, M., P. D. Katsikis, E. Abney, S. Parry, R. O. Williams, R. N. Maini, and M. Feldmann. 1996. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:495.
49. Tanaka, Y., T. Otsuka, T. Hotokebuchi, H. Miyahara, S. Nakashima, Y. Kuga, H. Nemoto, H. Niiro, and Y. Niho. 1996. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm. Res. 45:283.
50. Persson, S., A. Mikulowska, S. Narula, A. O'Garra, and R. Holmdahl. 1996. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand. J. Immunol. 44:607.
51. Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868.
52. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
53. De Vries, J. E. 1995. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27:537.
54. Qin, L., Y. Ding, D. R. Pahud, N. D. Roson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin 10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365.
55. Evans, C. H., P. D. Robbins, S. Ghivizzani, J. Herndon, R. Kang, A. Bahnson, J. Barrnager, E. Elders, S. Gay, M. Tomaino et al. 1996. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther. 7:1261.
56. Roessler, B. J., E. D. Allen, J. M. Wilson, J. W. Hartman, and B. L. Davidson. 1993. Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92:1085.
57. Ghivizzani, S. C., E. R. Lechman, C. Tio, K. M. Mule, S. Chada, J. E. McCormack, C. H. Evans, and P. D. Robbins. 1997. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy. Gene Ther. 4:977.
58. De Waal Malefyt, R. W., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, D. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915.
59. Ding, L., P. S. Linsley, L.-Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
60. Wooley, P. H., H. S. Luthra, J. M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688.
61. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
62. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J. Immunol. 151:2390.
63. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229.